Prognostic Factors, Treatment and Outcome in a Turkish Population with Endometrial Stromal Sarcoma |
Donertas, Ayla
(Department Obstetrics and Gynaecology, Tepecik Training and Research Hospital)
Nayki, Umit (Department Obstetrics and Gynaecology, Erzincan University, Medical Faculty) Nayki, Cenk (Department Obstetrics and Gynaecology, Erzincan University, Medical Faculty) Ulug, Pasa (Department Obstetrics and Gynaecology, Erzincan University, Medical Faculty) Gultekin, Emre (Department Obstetrics and Gynaecology, Tepecik Training and Research Hospital) Yildirim, Yusuf (Department Obstetrics and Gynaecology, Tepecik Training and Research Hospital) |
1 | Amant F, De Knijf A, Van Calster B, et al (2007). Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma. Br J Cancer, 97, 1194-9. DOI |
2 | Barney B, Tward JD, Skidmore T, Gaffney DK (2009). Does radiotherapy or lymphadenectomy improve survival in endometrial stromal sarcoma? Int J Gynecol Cancer, 19, 1232-8. DOI |
3 | Berchuck A, Rubin SC, Hoskins WJ, et al (1990). Treatment of endometrial stromal tumors. Gynecol Oncol, 36, 60-5. DOI |
4 | Bodner K, Adler BB, Obermair A, et al (2001). Prognostic parameters in endometrial stromal sarcoma: A clinicopathologic study in 31 patients. Gynecol Oncol, 81, 160-5. DOI |
5 | Brooks SE, Zhan M, Cote T, Baquet CR(2004). Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. Gynecol Oncol, 93, 204. DOI |
6 | Casali PG, Blay JY (2010). Soft tissue sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol, 21, 198-203. DOI ScienceOn |
7 | Chan JK, Kawar NM, Shin JY, et al (2008). Endometrial stromal sarcoma: a population- based analysis. Br J Cancer, 99, 1210-5. DOI ScienceOn |
8 | Chang KL, Crabtree GS, Lim-Tan SK, Kempson RL, Hendrickson MR (1990). Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases. Am J Surg Pathol, 14, 415-38. DOI |
9 | Chu MC, Mor G, Lim C, et al (2003). Low-grade endometrial stromal sarcoma: hormonal aspects. Gynecol Oncol, 90, 170-6. DOI |
10 | Durnali A, Tokluoglu S, Ozdemir N, et al (2012). Prognostic factors and treatment outcomes in 93 patients with uterine sarcoma from 4 centers in Turkey. Asian Pac J Cancer Prev, 13, 1935-41 DOI |
11 | Echt G, Jepson J, Steel J, et al (1990). Treatment of uterine sarcomas. Cancer, 66, 35-9. DOI |
12 | Gadducci A, Sartori E, Landoni F,et al (1996). Endometrial stromal sarcoma: analysis of treatment failures and survival. Gynecol Oncol, 63, 247-53. DOI |
13 | Gadducci A, Cosio S, Romanini A, Genazzani AR (2008). The management of patients with uterine sarcoma: A debated clinical challenge. Crit Rev Oncol Hematol, 65, 129-42. DOI ScienceOn |
14 | Gadduci A (2011). Prognostic factors in uterine sarcoma. Best Pract Res Clin Obstet Gynaecol, 25, 783-95. DOI |
15 | Garg G, Shah JP, Toy EP, et al (2010). Stage IA vs IB endometrial stromal sarcoma: does the new staging system predict survival? Gynecol Oncol, 118, 8-13. DOI |
16 | Geller MA, Argenta P, Bradley W, et al (2004). Treatment and recurrence in endometrial stromal sarcomas and the relation to c-kit expression. Gynecol Oncol, 95, 632-6. DOI |
17 | Ghaemmaghami F, Zarchi MK, Gilani MM, et al (2008). Uterine sarcoma: Clinicopathological characteristics, treatment and outcome in İran. Asian Pac J Cancer Prev, 9, 421-6. |
18 | Goff BA, Rice LW, Fleishhacker D, et al (1993). Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence. Gynecol Oncol, 50, 105-9. DOI |
19 | Haberal A, Kayikcioglu F, Boran N, et al (2003). Endometrial stromal sarcoma of the uterus: analysis of 25 patients. Eur J Obstet Gynecol Reprod Biol, 109, 209-13. DOI |
20 | Ihnen M, Mahner S, Jänicke F, Schwarz J (2007). Current treatment options in uterine endometrial stromal sarcoma: Report of a case and review of the literature. Int J Gynecol Cancer, 17, 957-63. DOI |
21 | Koss LG, Spiro RH, Brunschwig A (1965). Endometrial stromal sarcoma. Surg Gynecol Obstet, 121, 531-7. |
22 | Li N, Wu LY, Zhang HT, et al (2008). Treatment options in stage I endometrial stromal sarcoma: a retrospective analysis of 53 cases. Gynecol Oncol, 108, 306-11. DOI |
23 | Larson B, Silfversward C, Nilsson B, Pettersson F (1990). Endometrial stromal sarcoma of the uterus. A clinical and histopathological study. The Radiumhemmet series 1936-1981. Eur J Obstet Gynecol Reprod Biol, 35, 239-49. DOI |
24 | Leath CA, Huh WK, Hyde J, et al (2007). A multi-institutional review of outcomes of endometrial stromal sarcoma. Gynecol Oncol, 105, 630-4. DOI |
25 | Li AJ, Giuntoli RL, Drake R, et al (2005). Ovarian preservation in stage I low-grade endometrial stromal sarcomas. Obstet Gynecol, 106, 1304-8. DOI |
26 | Malouf GG, Duclos J, Rey A, et al (2010). Impact of adjuvant treatment modalities on the management of patients with stages I-II endometrial stromal sarcoma. Ann Oncol, 21, 2102-6. DOI |
27 | Maluf FC, Sabatini P, Schwartz L, Xia J, Aghajanian C (2001). Endomerial stromal sarcoma: objective response to letrozole. Gynecol Oncol, 82, 384-8. DOI |
28 | Mansi J.L, Ramachandra S, Wiltshaw E, Fisher C (1990). Endometrial stromal sarcomas. Gynecol Oncol, 36, 113-8. DOI |
29 | Moinfar F, Azodi M, Tavassoli FA (2007). Uterine sarcomas. Pathology, 39, 55-71. DOI |
30 | Nicolas ML, Cathro HP, Kerr SE, Stelow EB (2007). Cytomorphologic features of low-grade endometrial stromal sarcoma. AJR Am J Clin Pathol, 128, 265-71. DOI |
31 | Nicolas ML, Cathro HP, Kerr SE, Stelow EB (2007). Cytomorphologic features of low-grade endometrial stromal sarcoma. AJR Am J Clin Pathol, 128, 265-71. DOI |
32 | Reich O, Winter R, Regauer S (2005). Should lymphadenectomy be performed in patients with endometrial stromal sarcoma? Gynecol Oncol, 97, 982-3. |
33 | Norris HJ, Taylor HB (1966). Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumors. Cancer, 19, 755-66. DOI |
34 | Prat J (2009). FIGO staging for uterine sarcomas. Int J Gynaecol Obstet, 104, 177-8. DOI |
35 | Rauh-Hain JA, del Carmen MG (2013). Endometrial stromal sarcoma: a systematic review. Obstet Gynecol, 122, 676-83. DOI |
36 | Riopel J, Plante M, Renaud MC, Roy M, Tetu B (2005). Lymph node metastases in low- grade endometrial stromal sarcoma. Gynecol Oncol, 96, 402-6. DOI |
37 | Sagage S, Yamashita K, Ishioka S, et al (2004). Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan. Oncology, 67, 33-9 DOI |
38 | Spano JP, Soria JC, Kambouchner M, et al (2003). Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma. Med Oncol, 20, 87-93. DOI |
39 | Tanz R, Mahfoud T, Bazine A, et al (2012). Endometrial stromal sarcoma: prognostic factors and impact of adjuvant therapy in early stages. Hematol Oncol Stem Cell Ther, 5, 31-5. DOI |
40 | Tavassoli FA, Devilee P(2003) .World Health Organization classification of tumors. Mesenchymal tumors and related lesions. In: 'Pathology and genetics of tumors of the breast and female organs', Eds.Tavassoli FA and Devilee P. IARC Press, Lyon( France), 233-6. |
41 | Weitmann HD, Knocke TM, Kucera H, Potter R (2001). Radiation therapy in the treatment of stromal sarcoma. Int J Radiat Oncol Biol Phys, 41, 739-48. |
42 | Yamawaki T, Shimizu Y, Hasumi K (1997). Treatment of stage IV "high-grade" endometrial stromal sarcoma with ifosfamide, adriamycin, and cisplatin. Gynecol Oncol, 64, 265-9. DOI |
43 | Xue WC, Cheung AN (2011). Endometrial stromal sarcoma of the uterus. Best Pract Res Clin Obstet Gynaecol, 25, 719-32. DOI |